342 related articles for article (PubMed ID: 34123854)
1. Targeting Pyrimidine Metabolism in the Era of Precision Cancer Medicine.
Wang W; Cui J; Ma H; Lu W; Huang J
Front Oncol; 2021; 11():684961. PubMed ID: 34123854
[TBL] [Abstract][Full Text] [Related]
2. Revisiting the role of dihydroorotate dehydrogenase as a therapeutic target for cancer.
Madak JT; Bankhead A; Cuthbertson CR; Showalter HD; Neamati N
Pharmacol Ther; 2019 Mar; 195():111-131. PubMed ID: 30347213
[TBL] [Abstract][Full Text] [Related]
3. DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation.
Mullen NJ; Shukla SK; Thakur R; Kollala SS; Wang D; Chaika N; Santana JF; Miklavcic WR; LaBreck DA; Mallareddy JR; Price DH; Natarajan A; Mehla K; Sykes DB; Hollingsworth MA; Singh PK
bioRxiv; 2024 Jan; ():. PubMed ID: 37066260
[TBL] [Abstract][Full Text] [Related]
4. DHODH and cancer: promising prospects to be explored.
Zhou Y; Tao L; Zhou X; Zuo Z; Gong J; Liu X; Zhou Y; Liu C; Sang N; Liu H; Zou J; Gou K; Yang X; Zhao Y
Cancer Metab; 2021 May; 9(1):22. PubMed ID: 33971967
[TBL] [Abstract][Full Text] [Related]
5. Recent developments in the medicinal chemistry and therapeutic potential of dihydroorotate dehydrogenase (DHODH) inhibitors.
Vyas VK; Ghate M
Mini Rev Med Chem; 2011 Oct; 11(12):1039-55. PubMed ID: 21861807
[TBL] [Abstract][Full Text] [Related]
6. Cerpegin-derived furo[3,4-c]pyridine-3,4(1H,5H)-diones enhance cellular response to interferons by de novo pyrimidine biosynthesis inhibition.
Hayek S; Pietrancosta N; Hovhannisyan AA; Alves de Sousa R; Bekaddour N; Ermellino L; Tramontano E; Arnould S; Sardet C; Dairou J; Diaz O; Lotteau V; Nisole S; Melikyan G; Herbeuval JP; Vidalain PO
Eur J Med Chem; 2020 Jan; 186():111855. PubMed ID: 31740051
[TBL] [Abstract][Full Text] [Related]
7. Reactivation of Dihydroorotate Dehydrogenase-Driven Pyrimidine Biosynthesis Restores Tumor Growth of Respiration-Deficient Cancer Cells.
Bajzikova M; Kovarova J; Coelho AR; Boukalova S; Oh S; Rohlenova K; Svec D; Hubackova S; Endaya B; Judasova K; Bezawork-Geleta A; Kluckova K; Chatre L; Zobalova R; Novakova A; Vanova K; Ezrova Z; Maghzal GJ; Magalhaes Novais S; Olsinova M; Krobova L; An YJ; Davidova E; Nahacka Z; Sobol M; Cunha-Oliveira T; Sandoval-Acuña C; Strnad H; Zhang T; Huynh T; Serafim TL; Hozak P; Sardao VA; Koopman WJH; Ricchetti M; Oliveira PJ; Kolar F; Kubista M; Truksa J; Dvorakova-Hortova K; Pacak K; Gurlich R; Stocker R; Zhou Y; Berridge MV; Park S; Dong L; Rohlena J; Neuzil J
Cell Metab; 2019 Feb; 29(2):399-416.e10. PubMed ID: 30449682
[TBL] [Abstract][Full Text] [Related]
8. Dihydroorotate dehydrogenase (DHODH) inhibitors affect ATP depletion, endogenous ROS and mediate S-phase arrest in breast cancer cells.
Mohamad Fairus AK; Choudhary B; Hosahalli S; Kavitha N; Shatrah O
Biochimie; 2017 Apr; 135():154-163. PubMed ID: 28196676
[TBL] [Abstract][Full Text] [Related]
9. Lapachol, a compound targeting pyrimidine metabolism, ameliorates experimental autoimmune arthritis.
Peres RS; Santos GB; Cecilio NT; Jabor VA; Niehues M; Torres BG; Buqui G; Silva CH; Costa TD; Lopes NP; Nonato MC; Ramalho FS; Louzada-Júnior P; Cunha TM; Cunha FQ; Emery FS; Alves-Filho JC
Arthritis Res Ther; 2017 Mar; 19(1):47. PubMed ID: 28270195
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the mitochondrial pyrimidine biosynthesis enzyme dihydroorotate dehydrogenase by doxorubicin and brequinar sensitizes cancer cells to TRAIL-induced apoptosis.
He T; Haapa-Paananen S; Kaminskyy VO; Kohonen P; Fey V; Zhivotovsky B; Kallioniemi O; Perälä M
Oncogene; 2014 Jul; 33(27):3538-49. PubMed ID: 24013224
[TBL] [Abstract][Full Text] [Related]
11. Dihydroorotate dehydrogenase: A drug target for the development of antimalarials.
Singh A; Maqbool M; Mobashir M; Hoda N
Eur J Med Chem; 2017 Jan; 125():640-651. PubMed ID: 27721149
[TBL] [Abstract][Full Text] [Related]
12. Targeting of Hematologic Malignancies with PTC299, A Novel Potent Inhibitor of Dihydroorotate Dehydrogenase with Favorable Pharmaceutical Properties.
Cao L; Weetall M; Trotta C; Cintron K; Ma J; Kim MJ; Furia B; Romfo C; Graci JD; Li W; Du J; Sheedy J; Hedrick J; Risher N; Yeh S; Qi H; Arasu T; Hwang S; Lennox W; Kong R; Petruska J; Moon YC; Babiak J; Davis TW; Jacobson A; Almstead NG; Branstrom A; Colacino JM; Peltz SW
Mol Cancer Ther; 2019 Jan; 18(1):3-16. PubMed ID: 30352802
[TBL] [Abstract][Full Text] [Related]
13. PTEN Regulates Glutamine Flux to Pyrimidine Synthesis and Sensitivity to Dihydroorotate Dehydrogenase Inhibition.
Mathur D; Stratikopoulos E; Ozturk S; Steinbach N; Pegno S; Schoenfeld S; Yong R; Murty VV; Asara JM; Cantley LC; Parsons R
Cancer Discov; 2017 Apr; 7(4):380-390. PubMed ID: 28255082
[TBL] [Abstract][Full Text] [Related]
14. The dihydroorotate dehydrogenases: Past and present.
Reis RAG; Calil FA; Feliciano PR; Pinheiro MP; Nonato MC
Arch Biochem Biophys; 2017 Oct; 632():175-191. PubMed ID: 28666740
[TBL] [Abstract][Full Text] [Related]
15. Dihydroorotate dehydrogenase in oxidative phosphorylation and cancer.
Boukalova S; Hubackova S; Milosevic M; Ezrova Z; Neuzil J; Rohlena J
Biochim Biophys Acta Mol Basis Dis; 2020 Jun; 1866(6):165759. PubMed ID: 32151633
[TBL] [Abstract][Full Text] [Related]
16. A novel series of human dihydroorotate dehydrogenase inhibitors discovered by in vitro screening: inhibition activity and crystallographic binding mode.
Zeng T; Zuo Z; Luo Y; Zhao Y; Yu Y; Chen Q
FEBS Open Bio; 2019 Aug; 9(8):1348-1354. PubMed ID: 31087527
[TBL] [Abstract][Full Text] [Related]
17. Modulating pyrimidine ribonucleotide levels for the treatment of cancer.
Mollick T; Laín S
Cancer Metab; 2020; 8():12. PubMed ID: 33020720
[TBL] [Abstract][Full Text] [Related]
18. Pyrimidine Metabolism: Dynamic and Versatile Pathways in Pathogens and Cellular Development.
Garavito MF; Narváez-Ortiz HY; Zimmermann BH
J Genet Genomics; 2015 May; 42(5):195-205. PubMed ID: 26059768
[TBL] [Abstract][Full Text] [Related]
19. Dihydroorotate dehydrogenase inhibitors in anti-infective drug research.
Boschi D; Pippione AC; Sainas S; Lolli ML
Eur J Med Chem; 2019 Dec; 183():111681. PubMed ID: 31557612
[TBL] [Abstract][Full Text] [Related]
20. Assessment of drug candidates for broad-spectrum antiviral therapy targeting cellular pyrimidine biosynthesis.
Marschall M; Niemann I; Kosulin K; Bootz A; Wagner S; Dobner T; Herz T; Kramer B; Leban J; Vitt D; Stamminger T; Hutterer C; Strobl S
Antiviral Res; 2013 Dec; 100(3):640-8. PubMed ID: 24149002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]